Lance Friedman 13D and 13G filings for Aspire Biopharma Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-19 8:30 pm Sale | 2025-05-06 | 13G | ASPIRE BIOPHARMA HLDGS INC ASBP | Lance Friedman | 1,840 4.520% | -1,387 (-42.98%) | Filing |
| 2025-05-07 5:15 pm Sale | 2025-04-29 | 13G | ASPIRE BIOPHARMA HLDGS INC ASBP | Lance Friedman | 3,227 7.920% | -136 (-4.04%) | Filing |
| 2025-04-23 7:48 pm Sale | 2025-04-21 | 13G | ASPIRE BIOPHARMA HLDGS INC ASBP | Lance Friedman | 3,363 8.250% | -13 (-0.39%) | Filing |
| 2025-04-17 4:22 pm Sale | 2025-04-11 | 13G | ASPIRE BIOPHARMA HLDGS INC ASBP | Lance Friedman | 3,376 8.280% | -110 (-3.16%) | Filing |
| 2025-04-11 4:55 pm Sale | 2025-04-04 | 13G | ASPIRE BIOPHARMA HLDGS INC ASBP | Lance Friedman | 3,486 8.550% | -175 (-4.78%) | Filing |
| 2025-04-04 5:28 pm Sale | 2025-03-26 | 13G | ASPIRE BIOPHARMA HLDGS INC ASBP | Lance Friedman | 3,661 8.980% | -38 (-1.03%) | Filing |
| 2025-03-28 5:29 pm Sale | 2025-03-19 | 13G | ASPIRE BIOPHARMA HLDGS INC ASBP | Lance Friedman | 3,699 9.078% | -142 (-3.70%) | Filing |
| 2025-03-20 9:58 pm Sale | 2025-03-03 | 13G | ASPIRE BIOPHARMA HLDGS INC ASBP | Lance Friedman | 3,841 9.462% | -163 (-4.07%) | Filing |
| 2025-03-12 4:05 pm Sale | 2025-03-03 | 13G | ASPIRE BIOPHARMA HLDGS INC ASBP | Lance Friedman | 4,004 9.825% | -65 (-1.60%) | Filing |
| 2025-02-26 9:20 pm Purchase | 2025-02-17 | 13G | ASPIRE BIOPHARMA HLDGS INC ASBP | Lance Friedman | 4,069 9.980% | 4,069 (New Position) | Filing |